241 filings
Page 2 of 13
8-K
9m2svgfb g4k03aq
6 Nov 23
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
4:33pm
8-K
7r99c1lrcm5co
7 Sep 23
CRISPR Therapeutics Announces Leadership Transition
8:39am
S-8
0y2ztidllhyyckt6cp0
7 Aug 23
Registration of securities for employees
4:18pm
8-K
w5zmrh11pvps6
7 Aug 23
Results of Operations and Financial Condition
4:07pm
8-K
rw58hv 7yl
9 Jun 23
Departure of Directors or Certain Officers
4:29pm
8-K
8e3avn
9 Jun 23
Regulation FD Disclosure
7:07am
DEFA14A
egz4j5bfj 9sjh1
18 May 23
Additional proxy soliciting materials
4:16pm
8-K
conhxri
8 May 23
Results of Operations and Financial Condition
4:06pm
ARS
c7bv6
26 Apr 23
Annual report to shareholders
4:38pm
DEFA14A
m07 ahpy7ahn
26 Apr 23
Additional proxy soliciting materials
4:26pm
8-K
0frkzy0vxg7kk9pv
3 Apr 23
Regulation FD Disclosure
8:10am
8-K
bzwwgs4l uo6kjzxyc
29 Mar 23
CRISPR Therapeutics Announces Departure of Board Member
8:08am
8-K
y156r1tco
27 Mar 23
Entry into a Material Definitive Agreement
8:08am
8-K
ky9gt3
14 Mar 23
CRISPR Therapeutics Announces Transition of Chief Financial Officer
8:15am
8-K
ftb33k1id4rktmq y6
21 Feb 23
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
4:06pm